bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 3, 2024
Abstract
Determining
tumor
microsatellite
status
has
significant
clinical
value
because
tumors
that
are
instability-high
(MSI-H)
or
mismatch
repair
deficient
(dMMR)
respond
well
to
immune
check-point
inhibitors
(ICIs)
and
oftentimes
not
chemotherapeutics.
We
propose
MSI-SEER,
a
deep
Gaussian
process-based
Bayesian
model
analyzes
H&E
whole-slide
images
in
weakly-supervised-learning
predict
gastric
colorectal
cancers.
performed
extensive
validation
using
multiple
large
datasets
comprised
of
patients
from
diverse
racial
backgrounds.
MSI-SEER
achieved
state-of-the-art
performance
with
MSI
prediction,
which
was
by
integrating
uncertainty
prediction.
high
accuracy
for
predicting
ICI
responsiveness
combining
stroma-to-tumor
ratio.
Finally,
MSI-SEER’s
tile-level
predictions
revealed
novel
insights
into
the
role
spatial
distribution
MSI-H
regions
microenvironment
response.
Cancer Cell International,
Journal Year:
2025,
Volume and Issue:
25(1)
Published: March 21, 2025
Nowadays,
gastric
cancer
has
become
a
significant
issue
in
the
global
burden,
and
its
impact
cannot
be
ignored.
The
rapid
development
of
artificial
intelligence
technology
is
attempting
to
address
this
situation,
aiming
change
clinical
management
landscape
fundamentally.
In
transformative
change,
machine
learning
deep
learning,
as
two
core
technologies,
play
pivotal
role,
bringing
unprecedented
innovations
breakthroughs
diagnosis,
treatment,
prognosis
evaluation
cancer.
This
article
comprehensively
reviews
latest
research
status
application
algorithms
cancer,
covering
multiple
dimensions
such
image
recognition,
pathological
analysis,
personalized
risk
assessment.
These
applications
not
only
significantly
improve
sensitivity
monitoring,
accuracy
precision
survival
but
also
provide
robust
data
support
scientific
basis
for
decision-making.
integration
intelligence,
from
optimizing
diagnosis
process
enhancing
diagnostic
efficiency
promoting
practice
medicine,
demonstrates
promising
prospects
reshaping
treatment
model
Although
most
current
AI-based
models
have
been
widely
used
practice,
with
continuous
deepening
expansion
we
reason
believe
that
new
era
AI-driven
care
approaching.
Discover Oncology,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: April 1, 2025
Artificial
intelligence
(AI)
marks
a
frontier
in
histopathologic
analysis
shift
towards
the
clinic,
becoming
mainstream
choice
to
interpret
histological
images.
Surveying
studies
assessing
AI
applications
histopathology
from
2013
2024,
we
review
key
methods
(including
supervised,
unsupervised,
weakly
supervised
and
transfer
learning)
deep
learning-based
pattern
recognition
computational
for
diagnostic
prognostic
purposes.
Deep
learning
also
showed
utility
identifying
wide
range
of
genetic
mutations
standard
pathology
biomarkers
routine
histology.
This
survey
41
primary
encompasses
regions
applicability
multi-cancer
while
marking
prospects
introduce
into
clinical
setting
with
examples
including
Swarm
Learning
Data
Fusion.
Journal of Personalized Medicine,
Journal Year:
2025,
Volume and Issue:
15(5), P. 166 - 166
Published: April 24, 2025
Gastric
cancer
(GC)
remains
one
of
the
leading
causes
cancer-related
mortality
worldwide,
with
most
cases
diagnosed
at
advanced
stages.
Traditional
biomarkers
provide
only
partial
insights
into
GC’s
heterogeneity.
Recent
advances
in
machine
learning
(ML)-driven
multiomics
technologies,
including
genomics,
epigenomics,
transcriptomics,
proteomics,
metabolomics,
pathomics,
and
radiomics,
have
facilitated
a
deeper
understanding
GC
by
integrating
molecular
imaging
data.
In
this
review,
we
summarize
current
landscape
ML-based
integration
for
GC,
highlighting
its
role
precision
diagnosis,
prognosis
prediction,
biomarker
discovery
achieving
personalized
medicine.
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 16, 2025
Rapid
technological
advancements
have
made
it
possible
to
generate
single-cell
data
at
a
large
scale.
Several
laboratories
around
the
world
can
now
transcriptomic
from
different
tissues.
Unsupervised
clustering,
followed
by
annotation
of
cell
type
identified
clusters,
is
crucial
step
in
analyses.
However,
there
no
consensus
on
marker
genes
use
for
annotation,
and
celltype
currently
mostly
done
manual
inspection
genes,
which
irreproducible,
poorly
scalable.
Additionally,
patient-privacy
also
critical
issue
with
human
datasets.
There
need
standardize
automate
across
datasets
privacy-preserving
manner.
Here,
we
developed
SwarmMAP
that
uses
Swarm
Learning
train
machine
learning
models
cell-type
classification
based
sequencing
decentralized
way.
does
not
require
any
exchange
raw
between
centers.
has
F1-score
0.93,
0.98,
0.88
heart,
lung,
breast
datasets,
respectively.
Learning-based
yield
an
average
performance
0.907
par
achieved
trained
centralized
(
p
-val=
0.937
,
Mann-Whitney
U
Test).
We
find
increasing
number
increases
prediction
accuracy
enables
handling
higher
diversity.
Together,
these
findings
demonstrate
viable
approach
annotation.
available
https://github.com/hayatlab/SwarmMAP
.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 13, 2025
The
incidence
of
gastric
cancer
remains
high
and
poses
a
serious
threat
to
human
health.
Recent
comprehensive
investigations
into
amino
acid
metabolism
immune
system
components
within
the
tumor
microenvironment
have
elucidated
functional
interactions
between
cells,
metabolism.
This
study
reviews
characteristics
in
cancer,
with
particular
focus
on
methionine,
cysteine,
glutamic
acid,
serine,
taurine,
other
acids.
It
discusses
relationship
these
metabolic
processes,
development,
body’s
anti-tumor
immunity,
analyzes
importance
targeting
for
chemotherapy
immunotherapy.